CV Sciences, Inc. (CVSI) stock
CVSIOTCPharmaceutical PreparationsFiscal year ends December 31
$0.01−0.00 (-21.13%)
Close on Oct 19, 2026Market cap $2.53MP/E –Yield –
CV Sciences revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
CV Sciences's revenue for the twelve months ending Sep 30, 2026 was $12.52M, down 12.9% year over year. For fiscal 2025 it was $13.79M, down 12.2% from the year before. Over ten years it grew 1.8% a year on average. The highest annual figure on record is $53.70M in fiscal 2019.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $13.79M | -12.2% |
| FY2024 | Dec 31, 2024 | $15.71M | -1.9% |
| FY2023 | Dec 31, 2023 | $16.00M | -1.2% |
| FY2022 | Dec 31, 2022 | $16.21M | -19.2% |
| FY2021 | Dec 31, 2021 | $20.05M | -17.9% |
| FY2020 | Dec 31, 2020 | $24.43M | -54.5% |
| FY2019 | Dec 31, 2019 | $53.70M | +11.3% |
| FY2018 | Dec 31, 2018 | $48.24M | +133.3% |
| FY2017 | Dec 31, 2017 | $20.68M | +87.0% |
| FY2016 | Dec 31, 2016 | $11.06M | -4.1% |
| FY2015 | Dec 31, 2015 | $11.53M | +13.1% |
| FY2014 | Dec 31, 2014 | $10.19M | +373.1% |
| FY2013 | Dec 31, 2013 | $2.15M | – |
| FY2012 | Dec 31, 2012 | $0 | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $3.03M | -7.0% |
| Q2 FY2026 | Jun 30, 2026 | $2.99M | -17.5% |
| Q1 FY2026 | Mar 31, 2026 | $3.20M | -11.4% |
| Q4 FY2025 | Dec 31, 2025 | $3.31M | -14.9% |
| Q3 FY2025 | Sep 30, 2025 | $3.26M | -15.8% |
| Q2 FY2025 | Jun 30, 2025 | $3.62M | -8.4% |
| Q1 FY2025 | Mar 31, 2025 | $3.61M | -9.9% |
| Q4 FY2024 | Dec 31, 2024 | $3.88M | +2.2% |
| Q3 FY2024 | Sep 30, 2024 | $3.87M | -5.5% |
| Q2 FY2024 | Jun 30, 2024 | $3.95M | -0.3% |
| Q1 FY2024 | Mar 31, 2024 | $4.00M | -3.5% |
| Q4 FY2023 | Dec 31, 2023 | $3.80M | -1.8% |
| Q3 FY2023 | Sep 30, 2023 | $4.09M | +9.0% |
| Q2 FY2023 | Jun 30, 2023 | $3.97M | -4.2% |
| Q1 FY2023 | Mar 31, 2023 | $4.15M | -6.7% |
| Q4 FY2022 | Dec 31, 2022 | $3.87M | -22.1% |
| Q3 FY2022 | Sep 30, 2022 | $3.75M | -26.6% |
| Q2 FY2022 | Jun 30, 2022 | $4.14M | -19.3% |
| Q1 FY2022 | Mar 31, 2022 | $4.45M | -8.2% |
| Q4 FY2021 | Dec 31, 2021 | $4.97M | -4.4% |
| Q3 FY2021 | Sep 30, 2021 | $5.11M | -8.2% |
| Q2 FY2021 | Jun 30, 2021 | $5.13M | -5.0% |
| Q1 FY2021 | Mar 31, 2021 | $4.84M | -41.4% |
| Q4 FY2020 | Dec 31, 2020 | $5.20M | -44.3% |
| Q3 FY2020 | Sep 30, 2020 | $5.56M | -55.9% |
| Q2 FY2020 | Jun 30, 2020 | $5.40M | -68.0% |
| Q1 FY2020 | Mar 31, 2020 | $8.27M | -44.5% |
| Q4 FY2019 | Dec 31, 2019 | $9.33M | -34.4% |
| Q3 FY2019 | Sep 30, 2019 | $12.60M | -7.3% |
| Q2 FY2019 | Jun 30, 2019 | $16.85M | +36.5% |
| Q1 FY2019 | Mar 31, 2019 | $14.91M | +84.7% |
| Q4 FY2018 | Dec 31, 2018 | $14.22M | +96.4% |
| Q3 FY2018 | Sep 30, 2018 | $13.60M | +143.3% |
| Q2 FY2018 | Jun 30, 2018 | $12.35M | +202.5% |
| Q1 FY2018 | Mar 31, 2018 | $8.07M | +114.4% |
| Q4 FY2017 | Dec 31, 2017 | $7.24M | +125.6% |
| Q3 FY2017 | Sep 30, 2017 | $5.59M | – |
| Q2 FY2017 | Jun 30, 2017 | $4.08M | – |
| Q1 FY2017 | Mar 31, 2017 | $3.76M | – |
| Q4 FY2016 | Dec 31, 2016 | $3.21M | – |
See a number that looks wrong?